Oxytocin induced itching in a 37 week primigravida with meconium stained liquor
Introduction: Oxytocin is the most frequently used medication for labour augmentation in obstetrics. One of the known benefits of its use is the improvement of uterine contractions. An injectable form of oxytocin is administered intravenously as an infusion. Adverse drug reactions at this stage may distress the baby and worsen the outcome of the pregnancy.
Case details: A 19-year-old female with a history of nine months gestation presented in labour. She was administered oxytocin infusion in ringer lactate to augment labor. She developed itching all over her body and was immediately administered Inj. hydrocortisone intravenously. As the foetus was in distress, she was taken for an emergency lower segment cesarean section (LSCS).
Conclusion: The administration of IV oxytocin was considered the possible cause of the development of rashes in this case. We suggest adopting preventive strategies to avoid ADRs in emergencies to avoid deleterious consequences. The preventive strategies may include screening in the antenatal period for previous history of sensitivity to oxytocin, latex, etc. In addition, other strategies are discussed in this article.
Guo J, Ba X, Matsuda M, Wei P, Jiang C, Sun W, et.al. Oxytocin Elicits Itch Scratching Behavior via Spinal GRP/GRPR System. Front Neurosci.2020;14:581977. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538669/)
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions.Am J Hosp Pharm.1992;49:2229–32. (https://pubmed.ncbi.nlm.nih.gov/1524068/)
Joshi N, McMillan S. Drug Safety - Case Reports. Drug Saf Case Rep.2014;1(1):3. (https://pubmed.ncbi.nlm.nih.gov/27747470/)
Liccardi G, Bilò MB, Mauro C, Salzillo A, Piccolo A, D'Amato M, et al. Oxytocin: An unexpected risk for cardiologic and broncho-obstructive effects, and allergic reactions in susceptible delivering women Multidiscip Respir Med.2013; 8: 67. (https://mrmjournal.biomedcentral.com/articles/10.1186/2049-6958-8-67)
Li R, Sun H, Zheng H, Zong Z, Li S, Meng T, et.al. Intradermal Injection of Oxytocin Aggravates Chloroquine-Induced Itch Responses via Activating the Vasopressin-1a Receptor/Nitric Oxide Pathway in Mice. Front Pharmacol.2019;10:1380. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881818/)
MacDonald E, Dadds MR, Brennan JL, Williams K, Levy F, Cauchi AJ. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology.2011;36(8):1114-26. (https://pubmed.ncbi.nlm.nih.gov/21429671/)
Murthy SN and Kumar AH. Paracetamol Overdosing With 6500 mg Single Dose. Hospital Pharmacology.2022; 9(2):1170-75 (https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2022/2334-94922202170M.pdf)
Osilla EV, Sharma S. Oxytocin. [Updated 2022 Jul 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507848/. Accessed on 28 Nov 2022.
Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm.1992;27:538. (https://pubmed.ncbi.nlm.nih.gov/10118597/)
Viero, C., Shibuya, I., Kitamura, N., Verkhratsky, A., Fujihara, H., Katoh, A., et.al. REVIEW: Oxytocin: Crossing the Bridge between Basic Science and Pharmacotherapy. CNS Neuroscience & Therapeutics,2010;16: e138-e156. (https://pubmed.ncbi.nlm.nih.gov/20626426/)
Tang E, Ravaud P, Riveros C, Perrodeau E, Dechartres A. Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles. BMC medicine.2015;13:189. (https://pubmed.ncbi.nlm.nih.gov/26269118/)
The use of the WHO–UMC system for standardised case causality assessment. Available at: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf. Accessed on 28 Jul 2022.
Copyright (c) 2023 Dr Shiva Murthy Nanjundappa, Disha Sai M Chandavar, Dr. Nagendra Prasad N, Dr. Priyanka Reddy
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.